Incyte Corp (INCY)
53.78
+0.69
(+1.30%)
USD |
NASDAQ |
May 03, 16:00
53.78
0.00 (0.00%)
After-Hours: 20:00
Incyte Cash from Investing (Quarterly): -73.11M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -73.11M |
| December 31, 2023 | -154.50M |
| September 30, 2023 | -17.19M |
| June 30, 2023 | -7.429M |
| March 31, 2023 | -28.56M |
| December 31, 2022 | -20.91M |
| September 30, 2022 | -28.40M |
| June 30, 2022 | -12.48M |
| March 31, 2022 | -16.75M |
| December 31, 2021 | -66.05M |
| September 30, 2021 | -32.75M |
| June 30, 2021 | -49.14M |
| March 31, 2021 | -59.75M |
| December 31, 2020 | -102.73M |
| September 30, 2020 | -14.45M |
| June 30, 2020 | -43.26M |
| March 31, 2020 | -108.56M |
| December 31, 2019 | -30.03M |
| September 30, 2019 | 12.28M |
| June 30, 2019 | -45.15M |
| March 31, 2019 | -24.56M |
| December 31, 2018 | -36.10M |
| September 30, 2018 | -17.88M |
| June 30, 2018 | -3.922M |
| March 31, 2018 | -28.53M |
| Date | Value |
|---|---|
| December 31, 2017 | -143.00M |
| September 30, 2017 | -30.84M |
| June 30, 2017 | -37.32M |
| March 31, 2017 | -138.82M |
| December 31, 2016 | -36.01M |
| September 30, 2016 | -9.952M |
| June 30, 2016 | -215.28M |
| March 31, 2016 | 28.76M |
| December 31, 2015 | -4.529M |
| September 30, 2015 | -15.22M |
| June 30, 2015 | -26.69M |
| March 31, 2015 | -58.58M |
| December 31, 2014 | -3.518M |
| September 30, 2014 | -58.69M |
| June 30, 2014 | -28.54M |
| March 31, 2014 | -47.69M |
| December 31, 2013 | -19.93M |
| September 30, 2013 | -1.003M |
| June 30, 2013 | -15.70M |
| March 31, 2013 | -0.758M |
| December 31, 2012 | -0.50M |
| September 30, 2012 | -0.249M |
| June 30, 2012 | -0.91M |
| March 31, 2012 | -0.329M |
| December 31, 2011 | -1.139M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-154.50M
Minimum
Dec 2023
12.28M
Maximum
Sep 2019
-44.95M
Average
-31.39M
Median
Cash from Investing (Quarterly) Benchmarks
| Biogen Inc | -66.00M |
| Novartis AG | -899.00M |
| MorphoSys AG | -- |
| Illumina Inc | -85.00M |
| Pfizer Inc | -11.00B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 218.81M |
| Cash from Financing (Quarterly) | -12.41M |
| Free Cash Flow | 790.77M |
| Free Cash Flow Per Share (Quarterly) | 0.921 |
| Free Cash Flow to Equity (Quarterly) | 209.26M |
| Free Cash Flow to Firm (Quarterly) | 209.26M |
| Free Cash Flow Yield | 6.50% |